Overview

Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life

Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the current medical practice and its influence on health-related quality of life, in patients who are treated with injectable bone antiresorptive drugs (biphosphonates or denosumab) for at least one year.
Phase:
N/A
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon